Internal Medicine, Infectious Disease · Plano, TX
NPI
1336341619
Since 2007
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
4100 W 15th St, 100
Plano, TX, 75093
Phone (469) 408-9558
Groups this clinician bills Medicare through
Medicare paid, 2024
$274K
3,766 services
Medicare patients, 2024
437
Average age 76
Drug cost, 2024
$235K
744 prescriptions
Company payments, 2025
$52.06
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Srivalli Adari was code 99232 (hospital e&m - subsequent), 1,932 times for 392 patients. In total Srivalli Adari billed 3,766 services in 9 codes, and Medicare paid $274K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,932 | 392 | $54.09 | $104K |
| 99233 Hospital E&M - Subsequent | Facility | 1,223 | 351 | $81.49 | $100K |
| 99223 Hospital E&M - Initial | Facility | 470 | 386 | $118.98 | $56K |
| 99214 Office E&M - Established | Office | 68 | 25 | $88.69 | $6,031 |
| 99222 Hospital E&M - Initial | Facility | 35 | 34 | $90.11 | $3,154 |
| 99215 Office E&M - Established | Office | 21 | 19 | $110.52 | $2,321 |
By year: 2022 $282K for 3,788 services; 2023 $256K for 3,179 services; 2024 $274K for 3,766 services.
Medicare prescription drug claims, 2024
In 2024, the drug Srivalli Adari prescribed most often to Medicare patients was Daptomycin, with 207 prescriptions and refills. In total Srivalli Adari wrote 744 Medicare prescriptions that cost $235K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Daptomycin Generic | 207 | 207 | 33 | $112K |
| Cefepime Hcl Generic | 97 | 97 | 15 | $18K |
| Cephalexin Generic | 68 | 79 | 17 | $1,339 |
| Ceftriaxone Ceftriaxone Sodium | 53 | 53 | Under 11 | $2,018 |
| Meropenem Generic | 36 | 36 | Under 11 | $7,272 |
| Doxycycline Monohydrate Generic | 35 | 45 | 12 | $1,243 |
| Ertapenem Ertapenem Sodium | 33 | 33 | Under 11 | $6,564 |
| Fluconazole Generic | 31 | 35 | 15 | $772 |
| Doxycycline Hyclate Generic | 25 | 43 | Under 11 | $1,111 |
| Levofloxacin Generic | 19 | 19 | Under 11 | $72.91 |
| Cefepime Cefepime In Iso-Osm Dextrose | 14 | 14 | Under 11 | $6,472 |
| Vancomycin Hcl Generic | 14 | 14 | Under 11 | $2,878 |
| Micafungin Micafungin Sodium | 14 | 14 | Under 11 | $1,964 |
| Ciprofloxacin Hcl Generic | 13 | 15 | Under 11 | $328 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 13 | 15 | Under 11 | $142 |
Brand drugs: 51 claims; generic drugs: 693 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Srivalli Adari $52.06 ($52.06 in general payments such as food, travel and fees) from 1 company. The largest payer was Mallinckrodt Hospital Products Inc. with $52.06.
| Company | Payments | Amount |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 2 | $52.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.